Synairgen on takeover list Trial results and market potential may trigger a bid for asthma therapy developer
Feast On Dividends We explore what’s on the menu for investors wanting to earn a tasty income via stocks, funds and ETFs
Beeb bashing: Stock winners Reduced role for BBC post Charter renewal is positive for its commercial rivals